Advanced Search

    column
    Expert Consensus of Perioperative Treatment of Early Lung Cancer
    WU Yi-long, LU Shun, WANG Chang-li, WANG Jun, CHENG Ying, CHEN Xiao-yuan, CHEN Ming, WANG Qun, FAN Yun, CHUAI Shao-kun, WANG Xiao-nan, ZHANG Li, YANG Yue, YANG Fan, WANG Jie, CHEN Hai-quan, ZHI Xiu-yi, HU Cheng-ping, YANG Jin-ji, LIU Hong-xu, CAI Kai-can, ZHANG Xu-chao, LIU Yong-yu, HUANG Cheng, XU Lin, MAO Wei-min, ZHOU Qing-hua, KANG Xiao-zheng, LI Qiang, ZHANG Lan-jun, ZHOU Jian-ya, HUANG Yun-chao, WANG Bu-hai, WU Lin, XU Song-tao, ZHONG Wen-zhao, XU Shi-dong, YANG Nong, ZHU Zheng-fei, LIN Dong-mei, LIAO Ri-qiang, SONG Qi-bin, YANG Lin, LIU Zai-yi, CAI Xiu-yu, JIANG Feng, HU Yi, CHEN Yuan, MA Zhi-yong, QIAO Gui-bin, SONG Yong, LIN Geng, ZHAO Ming-fang, ZHOU Qing, LU You, YAN Xiao-long, WANG Zhi-jie, LIU Xiao-qing, MA Hai-tao, PENG Zhong-min, YUE Dong-sheng, SHI Wei-wei, LIAO Mei-lin, GUAN Zhong-zhen, CHEN Jing-hua,
    2019, 19(4): 193-199. DOI: 10.12019/j.issn.1671-5144.2019.04.001
    Abstract FullText HTML PDF
    An Interview at 2019 Chinese Lung Cancer Summit Forum
    ZHANG Yuan-dong, YU Lin, ZHANG Hua
    2019, 19(4): 200-209. DOI: 10.12019/j.issn.1671-5144.2019.04.002
    Abstract FullText HTML PDF
    The New Generation Always Excels Previous Ones: The Update of TKI Drugs
    XU Chong-rui, ZHOU Qing
    2019, 19(4): 210-211. DOI: 10.12019/j.issn.1671-5144.2019.04.003
    Abstract FullText HTML PDF
    Efficacy of Dacomitinib Versus Gefitinib as First-Line Treatment for Patients with EGFR Mutation Positive Non-Small Cell Lung Cancer
    WU Lin, FU Rui
    2019, 19(4): 212-216. DOI: 10.12019/j.issn.1671-5144.2019.04.004
    Abstract FullText HTML PDF
    Effect of Osimertinib in Untreated Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer
    KANG Xiao-zheng, SUN Hao
    2019, 19(4): 217-220. DOI: 10.12019/j.issn.1671-5144.2019.04.005
    Abstract FullText HTML PDF
    Application of Second-Generation ALK Inhibitor Brigatinib in ALK-Positive Non-Small Cell Lung Cancer
    SU Chun-xia, ZHAO Jing, ZHOU Fei, YANG Xiao-rong
    2019, 19(4): 221-224. DOI: 10.12019/j.issn.1671-5144.2019.04.006
    Abstract FullText HTML PDF
    ALEX Study: Make ALK Positive Advanced NSCLC Become Chronic Disease
    WANG Hui-juan, WEI Xue-wu
    2019, 19(4): 225-228. DOI: 10.12019/j.issn.1671-5144.2019.04.007
    Abstract FullText HTML PDF
    Saxagliptin Combined with Insulin Aspart 30 in Treatment of Elderly with TypeⅡDiabetes: A Meta-Analysis
    ZHENG Chao-jun, XU Jin-long, MA Wei-cheng
    2019, 19(4): 229-236. DOI: 10.12019/j.issn.1671-5144.2019.04.008
    Abstract FullText HTML PDF
    A Meta Analysis about The Screening of Cervical Intraepithelial Neoplasia Grade 2 or Worse between The HPV DNA Test and HPVE6/E7 mRNA Test
    YU Yang, ZHAO Juan, PEI Mei-li, JIA Hong-ran, YANG Xiao-feng
    2019, 19(4): 237-242. DOI: 10.12019/j.issn.1671-5144.2019.04.009
    Abstract FullText HTML PDF
    Meta-Analysis of Oxaliplatin Out of Instructive Indication Combined with Capecitabine in Treatment of Esophageal Cancer
    TIAN Zhao, YUAN Li-jun, WANG Wen-sheng, YIN Cong, LI Zhan-ying, LIU Qiang, YU Yuan-peng, TU Xing
    2019, 19(4): 243-251. DOI: 10.12019/j.issn.1671-5144.2019.04.010
    Abstract FullText HTML PDF
    Every Cloud Has A Silver Lining: Mixing Efficacy of An EGFR Mutated Advanced Lung Adenocarcinoma Case
    WANG Han-min, KANG Jing, CHEN Hua-jun, YANG Jin-ji,
    2019, 19(4): 252-256. DOI: 10.12019/j.issn.1671-5144.2019.04.011
    Abstract FullText HTML PDF